Pediatrix Medical (MD) Shares Outstanding (Weighted Average) (2009 - 2026)

Pediatrix Medical (MD) has 18 years of Shares Outstanding (Weighted Average) data on file, last reported at $80.9 million in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) fell 4.21% year-over-year to $80.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $80.9 million (down 4.21% YoY) and the FY2025 annual result came in at $84.4 million, up 1.33% from the prior year.
• Shares Outstanding (Weighted Average) retreated to $80.9 million in Q1 2026 per MD's latest filing, from $84.4 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $85.4 million in Q1 2022 and bottomed at $80.9 million in Q1 2026.
• The 5-year median for Shares Outstanding (Weighted Average) is $83.3 million (2024), against an average of $83.3 million.
• The widest annual swing landed in 2025, when Shares Outstanding (Weighted Average) gained 1.9%; it then declined 4.21% in 2026.
• Tracing MD's Shares Outstanding (Weighted Average) over 5 years: stood at $83.5 million in 2022, then declined by 1.52% to $82.2 million in 2023, then grew by 1.37% to $83.3 million in 2024, then gained by 1.33% to $84.4 million in 2025, then decreased by 4.21% to $80.9 million in 2026.
• Per Business Quant, the three latest MD Shares Outstanding (Weighted Average) figures stand at $80.9 million (Q1 2026), $84.4 million (Q4 2025), and $84.6 million (Q3 2025).

Peer Comparison